T 3 plays an important role in the regulation of cell growth and differentiation. In this study, we show the interactive effects of T 3 and androgens on the growth response and expression of the prostatespecific genes, PSA (prostate-specific antigen) and hK2 (human glandular kallikrein), in the human prostate cancer cell line, LNCaP. T 3 alone showed pronounced growth enhancement in a dose-dependent fashion. However, in the presence of androgens, higher concentrations of T 3 were required to produce additional proliferative effects. T 3 , androgens, or a combination of the two up-regulated PSA protein production in a dose-dependent fashion, but T 3 had little stimulatory effect on hK2 protein expression, regardless of the presence or absence of androgens.
scriptional activation of a reporter gene mediated by the PSA or hK2 enhancer/promoters. T 3 potentiated the androgen-mediated transcription of the PSA gene but not that of the hK2 gene. A previous study suggested that the T 3 effect on PSA protein expression was caused by an up-regulation of the androgen receptor (AR) protein by T 3 . Our results contradict these. Although AR expression was increased by T 3 alone, Western blot analysis showed that the total cellular AR level was not further increased by T 3 in the presence of androgens, in comparison with cells stimulated by androgens alone. Both Western blot analysis and a gel DNA band shift assay revealed that nuclear AR was not increased by T 3 . This study suggests that transcription factor(s) other than the AR may mediate T 3 enhancement of androgenic induction of PSA expression. (Endocrinology 140: [1665] [1666] [1667] [1668] [1669] [1670] [1671] 1999) A NDROGENS PLAY a critical role in cell proliferation, differentiation, maintenance, and function of the prostate. Also, extracellular, nonandrogen factors may be involved in many cellular events in the prostate. These factors (e.g. growth factors) may work in conjunction with androgens to modulate some cellular process (1) (2) (3) . Although thyroid hormone (T 3 ) has been shown to be an important regulator of growth and differentiation in many cell types, its effects on prostate cells are not well understood. Recently, Sakurai et al. (4) and Esquenet et al. (5) have reported expression of thyroid hormone receptor messenger RNA (mRNA) and protein in human prostate tissues and cell lines. Headland et al. (6) have suggested that T 3 is critical for supporting the growth of prostatic carcinoma cells. Thus, the questions arise as to what role thyroid hormones play and whether they interact with androgens in the regulation of the growth and differentiation of prostate cells.
The LNCaP cell line, which was derived from a human prostate cancer lymph node metastasis, is well differentiated and androgen responsive. It still exhibits many phenotypic features similar to that of normal prostate epithelia. For example, LNCaP cells express androgen, thyroid hormone, and several other nuclear receptors, as well as a number of tissuespecific differentiation markers, such as prostate-specific antigen (PSA), human glandular kallikrein (hK2), and prostatic acid phosphatase (7) (8) (9) (10) . The androgen receptor (AR) in LNCaP cells contains a single point mutation, which alters its steroid specificity but otherwise functions normally (11, 12) . However, in response to androgen deprivation, LNCaP cells exhibit a low level of in vitro apoptosis and a partial in vivo apoptosis (13) . In this paper, we used LNCaP cells to study the interactive effects of T 3 and androgens on the regulation of the prostate-specific differentiation marker genes, PSA and hK2. We also studied the effect of T 3 and androgens on proliferation of prostate cells.
Materials and Methods

Cell cultures and treatments
The human prostate cancer cell lines LNCaP and PC-3 were obtained from The American Type Culture Collection (Rockville, MD), and propagated in Corning 24-well or 96-well culture dishes, at a desired density, with RPMI 1640 (Celox Laboratories, Inc., St. Paul, MN) medium supplemented with 5% FBS (Biofluids, Rockville, MD) at 37 C and 5% CO 2 . After 24 h, the medium was changed to phenol red-free, serum-free RPMI 1640 medium, and the cells were incubated for an additional 24 h to deplete endogenous hormones before experiments. T 3 was purchased from Sigma Chemical Co. (St. Louis, MO), and a stock solution (1 m) was prepared in 1 n NaOH and diluted in RPMI 1640 medium. A synthetic androgen, mibolerone (Mib), was used in these studies because it is not metabolized by LNCaP cells, and its affinity to the AR is similar to that of the natural androgen, dihydrotestosterone. Mib was dissolved in ethanol. Equivalent amounts of solvent were added to control wells.
For PSA and hK2 expression, LNCaP cells were seeded at 4 ϫ 10 4 / ml⅐well in 24-well dishes and treated with different concentrations of T 3 , either with or without 1 nm Mib. After a 7-day incubation, spent media were harvested, and PSA and hK2 were quantified by an immunometric assay, as described below. Cell density was quantified by a cell prolif-eration assay described below. The concentrations of PSA and hK2 were normalized by cell density measurements and expressed as ng/ml⅐A490 (A490 is absorbance at 490 nm).
Cell proliferation assays
Cell proliferation was measured with a nonradioactive assay. Solutions containing the tetrazolium compound [3-(4,5-dimethylthiazol)-2-yl-5-(3-carboxymeth-oxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS)] and an electron coupling reagent (phenazine methosulfate) were used in the assay (14) . MTS is bioreduced by metabolically active cells into a formazan that is soluble in tissue culture medium. The absorbance of the formazan product was read at 490 nm. This absorbance is directly proportional to the number of living cells in culture (data not shown). All reagents were purchased from Promega Corp. (Madison, WI). Cells were incubated with freshly prepared, combined MTS/phenazine methosulfate (ratio of 1:1 by volume) solution for 1.5 h at 37 C in a humidified 5% CO 2 atmosphere.
Immunoassays for PSA and hK2 quantitation
Monoclonal antibodies (mAbs) against hK2 were developed in collaboration with Hybritech Inc. (San Diego, CA) (15) (16) (17) . PSA levels in culture supernatant were determined by an immunoenzymatic assay using the Tandem-E PSA kit (Hybritech Inc.). Levels of hK2 were measured by an immunometric sequential (sandwich) assay with mAbs. Details have been described previously (17) . Briefly, the capture antibody was coated on quarter-inch polystyrene beads (Clifton Plastics, Ltd., Fort Erie, Ontario, Canada) at 1 g of antibody per bead, and the detection antibody was prelabeled with acridinium ester. Recombinant hK2 (2,500 ng/ml, Hybritech Inc.) was serially diluted into assay diluent and used as an antigen in the standard curve. The capture antibody on the beads was incubated with the analyte in the sample or standard hK2 solution for 2 h at 37 C. Unbound antigen was washed away. The detecting antibody, labeled with acridinium ester, was added to the bead and incubated for 2 h at 37 C. Unreacted, excess antibody was removed by washing, leaving the antigen sandwiched between the two mAbs on the beads. The chemiluminescent signal (expressed as relative light units) was detected in a Magic Lite Analyzer II (Chiron Diagnostic Corp., Norwood, MA). Concentrations of hK2 were calculated from the standard curve derived from linear regression of the relative light units data.
Transient transfection assay
LNCaP cells were grown under the same conditions as described above. After depletion of steroids, cells were transfected with pBLCAT3 containing either the PSA enhancer/promoter (PSA E-407), as reported previously (17) , or the hK2 5-kb promoter, using liposomes containing DDAB (dimethyldioctadecyl-ammonium bromide) and L-a-lecithin (4: 10) under serum-free conditions. The ␤-gal-CMV vector (pCMVB, CLONTECH Laboratories, Inc., Palo Alto, CA) was cotransfected to normalize for transfection efficiency. The parental vector pBLCAT3 was used as a control. After transfection, cells were treated with Mib, T 3 , both, or vehicle for 24 h in 5% charcoal-stripped FBS-RPMI 1640 culture medium. Charcoal was used to remove the endogenous steroids from the serum. Cell extracts were prepared from duplicate plates and used for chloramphenicol acetyltransferase (CAT) and ␤-galactosidase assays, according to a published method (18) . Three independent transfections were performed.
Nuclear extracts
LNCaP cells were grown under the same conditions as described above, except that, before nuclear extraction, the cells were treated with or without 1 nm Mib Ϯ 10 Ϫ7 m T 3 in the presence of 5% charcoal-stripped FBS for 24 h. Nuclear extracts were prepared as described (19) . Briefly, cells were collected with Ca 2ϩ , Mg 2ϩ -free PBS containing 1 mm EDTA and were centrifuged at 1,000 rpm at 4 C for 10 min in a JA 68 rotor (Beckman Coulter, Inc., Fullerton, CA). The cell pellet was washed with ice-cold PBS, resuspended in 10 ml buffer containing 15 mm Tris-HCl (pH 7.5), 1 mm EDTA, 10% glycerol, and 2 mm dithiothreitol (DTT) and was centrifuged for 10 min at 5,000 rpm in a JA20 rotor from Beckman Coulter, Inc. The pellet was resuspended in the same buffer (3 ml), homogenized with 20 strokes of a B pestle in a dounce homogenizer, and centrifuged at the same speed to remove the supernatant. The crude nuclear pellet was resuspended in 0.5 ml buffer containing 20 mm HEPES (pH 7.9), 20% glycerol, 0.6 m NaCl, 1.5 mm MgCl 2 , 0.2 mm EDTA, 2 mm DTT, and 0.5 mm phenylmethanesulfonyl fluoride (PMSF) and was homogenized with 40 strokes. The homogenate was incubated in an ice bath for 30 min with resuspension every 5 min and then centrifuged at 15,000 rpm at 4 C in a JA 20 rotor for 30 min. The supernatant was collected and dialyzed against 100 vol of a buffer containing 20 mm HEPES (pH 7.5), 20% glycerol, 100 mm NaCl, 0.2 mm EDTA, 5 mm MgCl 2 , 2 mm DTT, 0.5 mm PMSF, and 1 nm Mib for 4 h with one change of buffer. The dialyzed nuclear extract was centrifuged at the same speed for 20 min to remove insoluble matter and was stored frozen at Ϫ100 C in small aliquots. The protein concentration of nuclear extracts was measured using a Bradford protein assay kit (Bio-Rad Laboratories, Inc., Hercules, CA).
Gel band shift experiments
Double-stranded oligonucleotides, containing the sequence of an androgen-responsive element (ARE) in either the PSA or the hK2 promoters (18, 20) 
Western blot analysis
For immunoblotting of the AR, LNCaP cells were grown under the same conditions described above and were treated without or with 10 Ϫ7 -2ϫ10 Ϫ9 m T 3 in the presence or absence of Mib (10 Ϫ9 m) plus 5% charcoal-stripped FBS. Nuclear extracts were prepared as described above. Whole-cell lysates were prepared using a lysis buffer containing 62.5 mm Tris, 10% SDS, and 25 mm DTT. Protein contents were quantified by either the Bradford assay (Bio-Rad Laboratories, Inc.) or the DC assay (Bio-Rad Laboratories, Inc.). Proteins were separated in 8% polyacrylamide SDS gels and electrotransferred onto sheets of nitrocellulose (Bio-Rad Laboratories, Inc.). High-molecular-weight protein markers (Amersham Corp.) were also included in gel electrophoresis. The blots were blocked overnight with 5% nonfat milk in TBST buffer (20 mm Tris-HCl, 137 mm NaCl, and 0.1% Tween 20) and incubated with an AR antibody (PharMingen) in 1:2000 dilution, and the same membrane was probed separately with ␤-tubulin (Sigma Chemical Co.). The AR and ␤-tubulin proteins were visualized by an antimouse IgG antibody conjugated with horseradish peroxidase (1:2000 dilution), enhanced chemiluminescence substrate (ECL, Amersham Corp.), and exposure to x-ray film. A densitometer was used to quantify the specific bands of AR and tubulin. The AR level is normalized by AR/tubulin.
Statistics
Statistical analysis was performed by ANOVA followed by Student's t test. A value of P Ͻ 0.05 was considered statistically significant.
Results
The first question we addressed was whether T 3 , either alone or in combination with the synthetic androgen, Mib, had any effect on the growth properties of LNCaP cells. As shown in Fig. 1A , cells treated with T 3 alone showed pronounced growth enhancement in a dose-dependent fashion (P Ͻ 0.01). Interestingly, Mib seemed to attenuate the growth enhancement achieved by T 3 at 10 Ϫ8 and 10 Ϫ9 m. In the presence of Mib, significant cell proliferative activity (P Ͻ 0.05) was achieved only with high concentrations of T 3 (10 Ϫ7 m). We also examined whether T 3 had a stimulatory effect on the growth of an androgen-independent cell line, PC-3. As shown in Fig. 1B , the growth of PC-3 cells was significantly stimulated by T 3 , though high concentrations of T 3 were required (10 Ϫ7 -10 Ϫ5 m). Because PC-3 cells lack androgen responsiveness, experiments for the interactive effects of T 3 and androgens were not performed in this cell line.
We next investigated the interactive effects of thyroid hormone and androgens on gene expression in LNCaP cells. We used PSA and hK2 as markers. PSA and hK2 are prostatespecific proteins (19, 20) whose expression is up-regulated by androgens and therefore serve as differentiation markers in prostate cells. We have recently developed a highly specific and sensitive immunoassay for the hK2 protein (15) . We used this assay, along with the PSA Tandem-E assay, to evaluate the effects of T 3 on the expression of hK2 and PSA, in the presence or absence of androgens. As seen in Fig. 2A, T 3 , together with androgen, enhanced the androgen-induced up-regulation of PSA expression in a dose-dependent manner. In contrast, in the absence of androgen, PSA expression was very low; and T 3 alone had only a marginal effect on its expression [2-fold at the highest concentration treated (10 Ϫ7 m)]. When hK2 expression was examined (Fig. 2B) , it was found that T 3 had no additional stimulation effect over that afforded with androgen alone. Moreover, in the absence of androgen, T 3 slightly inhibited hK2 expression. These data suggest that the effects of T 3 on the differentiation properties (i.e. PSA and hK2 expression) may be different from the effects on the proliferation properties of prostate cells.
To determine the mechanism by which T 3 affects the androgenic induction of PSA and hK2 gene expression, gene transfer studies were initiated. In these studies, LNCaP cells were transfected with either the PSA-or hK2 promoter/ enhancer, linked to a CAT-reporter and incubated with T 3 and/or Mib. As shown in Fig. 3 , Mib was a potent inducer of both PSA and hK2 transcription activities, which is in agreement with previous studies (20, 21) . The PSA enhancer/ promoter was induced by Mib to a greater extent than that of hK2, which is in agreement with the above observations on protein expression. T 3 potentiated the androgenic induction of the PSA enhancer/promoter (P Ͻ 0.05) but not that of hK2 (P ϭ 0.65). T 3 alone had no significant effect on transcriptional activity of either the PSA or hK2 genes.
Recently, it has been suggested that the enhancement of PSA protein expression by T 3 , in the presence of androgens, may be caused by the up-regulation of the AR protein by T 3 (5) . To test this hypothesis, we used a gel-shift assay to quantify functional AR in LNCaP nuclear extracts, 24 h after treatment with T 3 and/or Mib. Our results showed that there were no significant differences in supershifted AR-ARE complexes between the treatments of androgen and androgen combined with T 3 , regardless of whether PSA ARE or hK2 ARE was used (Fig. 4) . These results suggest that the nuclear AR protein level is not increased by T 3 during a time when the transcription rate for the PSA gene is increased.
To further test this hypothesis, a Western blot analysis was performed. We first examined AR levels in whole-cell lysates after treatments with increasing concentrations of T 3 and/or a constant concentration of Mib. As shown in Fig. 5a , total AR protein was readily increased by T 3 , at 2 ϫ 10 Ϫ9 m. Although androgens increased AR levels, as expected, T 3 (at all concentrations tested) did not further enhance AR protein levels. Next, AR levels were measured in whole-cell lysates and nuclear extracts from LNCaP cells, after treatment with T 3 at 4 /well in serum-free media were treated with T 3 (10 Ϫ10 -10 Ϫ7 M) Ϯ a synthetic androgen, Mib (1 nM). The spent media were collected 7 days post stimulation and used for PSA or hK2 assays, as described in Materials and Methods. Final cell density was assayed by the colormetric MTS assay, according to instructions from Promega Corp.. The concentrations of PSA and hK2 were normalized by cell density and expressed as ng/ml/A490. Error bars, SD of the mean of three separate experiments; *, statistical significance at P Ͻ 0.05, compared with control. FIG. 3 . Effects of T 3 and androgens on transcription activities of the enhancer/promoter of the PSA and hK2 genes. LNCaP cells in duplicate plates were transfected with PSA enhancer-promoter-pBLCAT3 or hK2-pBLCAT3 constructs (4 g/plate), as described in Materials and Methods, and treated with either vehicle, 1 nM Mib, 10 Ϫ7 M T 3 , or both Mib and T 3 , for 24 h. Parental vector was used as control. A ␤-gal-CMV vector was cotransfected to normalize for transfection efficiency. Cell extracts were prepared and used for CAT activity and ␤-gal assays. The diagram shows the results of the CAT assay, as expressed in (cpm/min)/mU ␤-gal. Error bars, SD of the mean of three separate experiments; *, statistical significance at P Ͻ 0.05, compared with control. Ϫ7 m and/or Mib, in two independent experiments (a representative result is shown in Fig. 5b ). When nuclear extracts were examined, it was found that the immunostained band from the T 3 -treated cells migrated faster than that from cells treated with either T 3 and Mib or Mib alone. Furthermore, T 3 treatment resulted in a small increase in AR expression in nuclear extracts, but no further enhancement of AR levels was observed in the presence of androgens. This is consistent with the results of the above band-shift assays. Moreover, in nuclear extracts, androgen treatment resulted in a slower migrating band on the gel. Because hyperphosphorylation of the AR, induced by androgens, results in slower migration in SDS-PAGE gel (22, 23) , these results are consistent with a change in the phosphorylation status of the protein. T 3 treatment did not seem to alter the migration status of the AR in either whole-cell lysates or nuclear extracts. Thus, it may not affect the phosphorylation status of the protein.
Discussion
Thyroid hormone/receptors play multiple regulatory roles in the developmental processes of vertebrates. It has been reported that thyroid hormones can protect cells from apoptotic cell death by up-regulating the Bcl-2 protein (24). T 3 also increases production of insulin-like growth factor (IGF) and IGF binding protein-3 in rat pituitary tumor cells (25) . It has been suggested that T 3 can regulate extracellular modeling proteases, which may be implicated in breast cancer development and metastasis (26) . T 3 receptors have also been detected in normal and cancerous prostate cells (5) . Our studies demonstrate proliferative effects of T 3 on human prostate cancer cells, both androgen-responsive and nonresponsive. Thus, it warrants further study as to whether growth factors, their receptors, or other autocrine factors are the downstream mediators for thyroid hormone action for growth of prostate cells.
Although the mechanism(s) by which thyroid hormones and androgens mediate the positive growth responses in prostate cells are still poorly understood, our present study suggests that the growth responses of LNCaP cells stimulated by thyroid hormone are not identical to that stimulated by androgens. Moreover, T 3 can enhance androgenic induction of PSA expression, suggesting that T 3 may further enhance the androgen-stimulated differentiation of prostate cells. Thus, the growth pathways regulated by the two agents may be, at least in part, separate. Moreover, T 3 seems less potent for growth stimulation of PC-3 cells. Whether this is an indication that highly hormone-refractory cells become less thyroid hormone dependent is not clear.
We (20) and others (21, 27) have established that the expression of PSA and hK2 genes are regulated primarily at the transcriptional level by ligand-activated AR via ARE in the promoters of these two genes. As shown in our previous studies (20) , the increase of mRNA of both PSA and hK2 parallel the increase of these two proteins after androgenic induction. Our present studies show that androgen-induced PSA protein expression was enhanced by T 3 , but under the same conditions, hK2 protein levels were not effected. Gene transfer experiments with PSA and hK2 enhancer/promoters showed consistent results with the protein expression of these two genes, suggesting that the T 3 effects occur, at least in part, at the transcriptional level. Moreover, although T 3 alone increased the total cellular AR level and slightly increased the nuclear AR level, it did not further increase the nuclear AR level over androgen treatment alone.
It is well established that androgens can enhance AR protein levels by increasing the half-life, as well as by stimulating the phosphorylation, of the AR (28 -30) . Whether the enhanced phosphorylation increases the stability of the AR is not clear. However, agonist-bound AR is more resistant to in vitro proteolytic digestion, indicating a conformational change of the AR induced by androgens. Thus, a conformation change may expose sites for phosphorylation by protein kinases (22) . It has been suggested that phosphorylation may play a role in many diverse processes for nuclear receptors: ligand binding, translocation to the nucleus, dimerization, DNA binding, and interaction with other proteins (22) . Phosphorylation of the AR by androgens results in an altered migration on an SDS-PAGE gel, as evidenced in previous reports (23) and suggested by this study. T 3 alone did not seem to change the phosphorylation status of the AR. This may explain why T 3 alone did not exhibit significant effects on transactivation of either the PSA or hK2 genes. Furthermore, although T 3 alone increased AR protein expression, the expression of androgen-regulated genes, such as PSA and hK2, was not drastically increased by T 3 . This further suggests the importance of androgen-induced phosphorylation. Moreover, how T 3 alone can affect AR levels remains to be elucidated.
Because T 3 did not seem to stimulate either phosphorylation of the AR or activation of transcription of the PSA and hK2 genes, it is puzzling why T 3 , in the absence of androgens, could enhance the expression of PSA, yet repress the expression of hK2. Whether T 3 can modulate the secretion of PSA and hK2 proteins remains to be determined. Nonetheless, the effects of T 3 on androgenic induction of these two genes at the transcriptional levels cannot simply be explained by the levels of AR protein. The question, therefore, arises as to whether T 3 enhances PSA transcription via the T 3 receptor and its cognate responsive elements in the PSA gene. If this is the case, perhaps AR binding to the PSA promoter is a prerequisite for T 3 receptor-mediated enhancement of transactivation. Currently, we are vigorously pursuing a study for identifying the T 3 receptor binding site in the PSA promoter.
